We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Satellite Technology Monitors HIV Diagnostic Equipment

By LabMedica International staff writers
Posted on 09 Dec 2008
A satellite feedback system monitors and maintains diagnostic equipment for human immunodeficiency virus (HIV)/AIDS in developing countries.

At the heart of the system is the portable equipment PointCare (Marlborough, MA, USA) NOW, which can do the complete regular monitoring of CD4 cell counts in adults, as well as CD4 percent testing, critical when treating young children. More...
Such testing, combined with the complete hematology profile that the NOW system provides, is essential to adjust effectively not only HIV antiretroviral therapy, but also holistic healthcare for the needs of each patient.

PointCare NOW, which is easy to use and can be run off a battery and other alternate types of power, yields, in less than eight minutes, a report on T-cell depletion, anemia, and abnormal white cell differentials.

With the PointCare satellite modem technology, when the NOW system closes down at clinics at the end of the day, the software on the NOW will collect all data on the operations for that day and upload to the modem. The information collected will be transmitted immediately via satellite to a server and entered into the ongoing profile of each NOW system.

The PointCare Technologies invented the satellite technology, which was introduced at the Corporate Council on Africa conference in Washington DC, USA on November 2008. Petra Krauledat, CEO of PointCare Technologies said, "We can essentially bring the laboratory to HIV/AIDS patients anywhere and deliver the complete monitoring they need to keep their medication on the right track. But as anyone who has worked with technology in developing countries knows, it is one thing to get the equipment out there, but another to maintain it. Now we can do that quite easily."

PointCare Technologies develops, manufactures, and markets medical diagnostic products. PointCare brings diagnostic capabilities to resource-limited urban and rural regions, enabling immediate identification and treatment of infectious diseases by healthcare professionals.

Related Links:

PointCare


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.